These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688 [TBL] [Abstract][Full Text] [Related]
17. Plasma cell acid phosphatase as an adjunct in the differential diagnosis of monoclonal immunoglobulinemias. Tortarolo M; Cantore N; Grande M; Buonanno G; Dammacco F Acta Haematol; 1981; 65(2):103-7. PubMed ID: 6785954 [TBL] [Abstract][Full Text] [Related]
18. Tartrate-resistant acid phosphatase (TRAP) activity in serum: potential use in assessing bone resorption in patients with multiple myeloma. Monti M; Scazzoso A; Calzaferri G; Santi I; D'Aprile E; Cunietti E Int J Biol Markers; 1990; 5(2):61-4. PubMed ID: 2283478 [TBL] [Abstract][Full Text] [Related]
19. Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma: relationship to the thymidine-labeling index. Boccadoro M; Gallamini A; Fruttero A; Gavarotti P; Redoglia V; Buffa F; Ruá S; Pileri A J Clin Oncol; 1985 Nov; 3(11):1503-7. PubMed ID: 4056842 [TBL] [Abstract][Full Text] [Related]
20. Myeloma bone marrow acid phosphatase staining: a correlative study of 38 patients. Bataille R; Durie BG; Sany J; Salmon SE Blood; 1980 May; 55(5):802-5. PubMed ID: 6767509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]